By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.
By Maria Dalby (article) and Esther Drain (interviews) Not only is the treatment ‘landscape’ in Hodgkin lymphoma (HL) changing rapidly both in the first-line and relapsed/refractory setting, but… read more.
by Christine Clark ISHL 2016 Professor Joseph Connors (Vancouver) speaks about the session at ISHL10 where a world view of the management of Hodgkin lymphoma was discussed. There… read more.
Vijayveer Bonthapally et al, Cambridge, MA, USA / by Maria Dalby. AETHERA is a randomised, placebo-controlled phase III study to evaluate whether consolidation treatment with brentuximab vedotin can… read more.
Zeinab Ali Abou Yehia et al, Houston, TX, USA / by Maria Dalby. PET-CT scans appear to be more sensitive than bone marrow biopsies for detecting bone marrow… read more.
John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby. Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.
Dr Andrew Davies, Southampton, UK, Professor John Radford, The University of Manchester, UK, Professor Peter Johnson, Southampton University, UK, Dr Karl Peggs, University College Hospital, London, Professor Stephen… read more.
Interview with Professor Joseph Connors, Vancouver, BC, Canada, who spoke for the motion in this key debate at ICML 2015. Interview by Esther Drain.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
